parthenolide and Cardiometabolic Syndrome

parthenolide has been researched along with Cardiometabolic Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barroso, E; Chacón, MR; Garrido-Sánchez, L; Maymó-Masip, E; Palomer, X; Salvadó, L; Serrano-Marco, L; Tinahones, FJ; Vázquez-Carrera, M; Vendrell, J; Wabitsch, M1

Trials

1 trial(s) available for parthenolide and Cardiometabolic Syndrome

ArticleYear
TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes.
    Biochimica et biophysica acta, 2012, Volume: 1821, Issue:9

    Topics: Active Transport, Cell Nucleus; Adipocytes; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cell Nucleus; Cells, Cultured; Female; Gene Expression Regulation, Enzymologic; Humans; Inflammation; Interleukin-6; Intra-Abdominal Fat; Male; Metabolic Syndrome; Middle Aged; Obesity; PPAR delta; PPAR-beta; Sesquiterpenes; Sirtuin 1; Transcription Factor RelA; Tumor Necrosis Factor-alpha

2012